Europe Ablation Technologies Market | Growth, Trends, and Forecast (2020

ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the report
- Key Market Trends
- Competitive Landscape
- Major Players
TABLE OF CONTENTS

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

5.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Rising incidences of diseases such as cancer and cardiac ailments are expected to boost the demand for ablation procedures. According to the 2020 report of European Heart Network, in collaboration with the WHO European Office for the Prevention and Control of Noncommunicable Diseases, around 3.9 million deaths in Europe and over 1.8 million deaths in the European Union occur due to cardiovascular diseases each year. It is expected that this number would increase further by 2030.The technological advancements to design high-end products and a growing demand for treatment procedures, which are minimally invasive are also expected to boost the ablation technologies market. Furthermore, the rising number of the aging population having a higher risk of target diseases is another vital factor driving the demand for ablation procedures.However, product recalls by companies are also hindering the growth of the market. Stringent regulatory framework leading to an increase in the gestation period for product launches is also a market challenge.

Scope of the report

Ablation Technologies is the treatment that destroys tumors or unwanted material without affecting other body tissues or organs. Because of poor health or reduced organ function, these techniques are widely used to treat cancer, cardiovascular, and other chronic diseases. In the treatment of chronic diseases, medical ablation plays a prime role in the removal or complete destruction of abnormal tissue.

By Type
		Laser/Light Ablation
		Radiofrequency Ablation
		Ultrasound Ablation
		Electrical Ablation
		Others

By Application
		General Surgery
		Cardiovascular Disease Treatment
		Cancer Treatment
		Ophthalmologic Treatment
		Gynecological Treatment
		Urological Treatment
		Orthopedic Treatment
		Cosmetic Surgery
		Other Treatments

Geography

Europe
	Germany
	France
	United Kingdom
	Italy
	Spain
	Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application of Ablation Devices in Cancer Treatment is Expected to register a Significant Growth Ra

The increase in the number of cancer patients has driven market growth. Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018.

Cancer ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. Therefore as the demand for minimally invasive surgeries is increasing, the demand for this alternative to cancer treatment is also increasing. Hence all these factors are expected to dominate the market.

To understand key trends, Download Sample Report

Competitive Landscape

Market leaders are increasing fundings for research & development and have retained their position in the market. The key market players operating in the Europe Ablation Technologies market include Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson, Medtronic, Inc., Olympus Corporation, Smith & Nephew PLC amongst others.

Major Players

You can also purchase parts of this report. Do you want to check out a section wise price list?

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Emergence of Next-generation Ablation Products and Technology
  2. 4.2.2 Growing Burden of Target Diseases
3. 4.3 Market Restraints
  1. 4.3.1 Stringent Regulatory Scenario
  2. 4.3.2 High Cost of Devices
4. 4.4 Value Chain / Supply Chain Analysis
5. 4.5 Porter's Five Forces Analysis
  1. 4.5.1 Threat of New Entrants
  2. 4.5.2 Bargaining Power of Buyers/Consumers
  3. 4.5.3 Bargaining Power of Suppliers
  4. 4.5.4 Threat of Substitute Products
  5. 4.5.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Type
  1. 5.1.1 Laser/Light Ablation
  2. 5.1.2 Radiofrequency Ablation
  3. 5.1.3 Ultrasound Ablation
  4. 5.1.4 Electrical Ablation
  5. 5.1.5 Others
2. 5.2 By Application
  1. 5.2.1 General Surgery
  2. 5.2.2 Cardiovascular Disease Treatment
  3. 5.2.3 Cancer Treatment
  4. 5.2.4 Ophthalmologic Treatment
  5. 5.2.5 Gynecological Treatment
  6. 5.2.6 Urological Treatment
  7. 5.2.7 Orthopedic Treatment
  8. 5.2.8 Cosmetic Surgery
  9. 5.2.9 Other Treatments
3. 5.3 Geography
  1. 5.3.1 Europe
    1. 5.3.1.1 Germany
    2. 5.3.1.2 France
    3. 5.3.1.3 United Kingdom
    4. 5.3.1.4 Italy
    5. 5.3.1.5 Spain
    6. 5.3.1.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Abbott Laboratories
  2. 6.1.2 Angiodynamics, Inc.
  3. 6.1.3 Atricure, Inc.
  4. 6.1.4 Biosense Webster, Inc.
  5. 6.1.5 Boston Scientific Corporation
  6. 6.1.6 Conmed Corporation
  7. 6.1.7 Johnson & Johnson
  8. 6.1.8 Medtronic, Inc.
  9. 6.1.9 Olympus Corporation
  10. 6.1.10 Smith & Nephew PLC

*List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments